RxDoctor Payments Data

Glenn Woods, MD

Anesthesiology · Opelika, ALNPI 1750346367

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $937 of the $1,242 with a category attached, or 75.4%. Boston Scientific accounts for 81.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $567 and has fallen 88.1% since, to $67 in 2025. Among anesthesiology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,242in general payments, 2019–2025

Across 29 payments — averaging $42.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Avanos Medical$116
  • Curonix LLC$52
  • SPR Therapeutics, Inc$31
  • Merck$19
  • Stimwave Technologies Incorporated$17

What the payments were for

  • Travel & lodging$27322%
  • Food & beverage$93775%
  • Education$333%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,242 in reported general payments places this provider in the 90th percentile of 484 anesthesiology providers in Alabama.

See all anesthesiology providers in Alabama

Medicare billing

Part B allowed, 2024
$58,734
Medicare patients
337
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fentanyl49$5,173
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen316$4,641
Gabapentin261$2,246
Pregabalin24$1,603
Celecoxib91$1,585
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen88$1,324
Diclofenac Sodium89$1,177
Tramadol Hcl133$750
Tizanidine Hcl106$706
Methadone Hcl54$569
Methocarbamol48$389
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen12$292
Meloxicam81$255
Duloxetine Hcl16$196
Baclofen17$141

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Opelika

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →